Search the Newsreel

ETFs Investing in Amneal Pharmaceuticals, Inc. Class A Stocks

This article lists various ETFs that include Amneal Pharmaceuticals, Inc. Class A stocks in their holdings. The data presented for each ETF includes market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year NAV …

AMN Healthcare Services (AMN) Stock Trades Near Fair Value After Its 119% Run

AMN Healthcare Services (AMN) has seen a significant 118.7% surge year-to-date, prompting a re-evaluation of its stock. While the Discounted Cash Flow (DCF) model suggests the stock is currently near its intrinsic value, the Price/Sales (P/S) ratio indicates it might be slightly overvalued when …

AMN Healthcare Services (NYSE:AMN) Stock Forecast & Analyst Predictions

AMN Healthcare Services (NYSE:AMN) is forecast to become profitable in the next three years, with earnings expected to grow by 14.8% annually and EPS by 18.5%. Despite a projected revenue decline of 12.7% per annum, analyst price targets have been rising due to factors …

Truist Financial Maintains AMN Healthcare Services(AMN.US) With Buy Rating, Announces Target Price $40

Truist Financial has reiterated its Buy rating for AMN Healthcare Services (AMN.US) and set a price target of $40. This indicates a positive outlook from the firm regarding the company's stock performance.

AMN stock trades steady as staffing demand supports recent earnings trends

AMN Healthcare Services Inc. (AMN) is a major U.S. healthcare staffing provider whose stock performance is influenced by demand for nurses, physicians, and allied health professionals. The company reported substantial revenue of around $4.36 billion in a recent fiscal year and maintains profitability through …

AMRX: Amneal Pharmaceuticals Inc - Ordinary Shares - Class A Latest Stock Price, Analysis, News and Trading Ideas

This article provides current stock information for Amneal Pharmaceuticals Inc (AMRX), including its latest stock price, market capitalization, volume, and key financial ratios. It also highlights recent news from Zacks indicating AMRX as a strong growth and momentum stock, along with discussions about other …

Smile Doctors Appoints Jeff Knudson as CFO to Help Scale Next Phase of Growth

Smile Doctors, the largest orthodontic support organization in the U.S., has appointed Jeff Knudson as its new Chief Financial Officer. Knudson, with prior CFO experience at NVA, AMN Healthcare Services, and At Home Group, will lead the company's financial strategy as it continues to …

How First-Generic OMNIPAQUE Rivals At Amneal Pharmaceuticals (AMRX) Have Changed Its Investment Story

Amneal Pharmaceuticals recently received FDA approval for additional strengths and vial sizes of its iohexol radiographic contrast injection, becoming the first generic version referencing OMNIPAQUE across these presentations. This expands Amneal's reach in a US$706 million market and supports its strategy of leaning on …

Amneal Pharmaceuticals stock hits 52-week high at 17.86 USD By Investing.com

Amneal Pharmaceuticals Inc. (AMRX) stock reached a new 52-week high of $17.86, trading at $17.87 with a market capitalization of $5.65 billion. This milestone follows a 116.75% increase over the past year, driven by strong financial performance including Q1 2026 EPS of $0.27 and …

AMN Healthcare acquires Jaide Health to expand AI-powered language services

AMN Healthcare has acquired Jaide Health to enhance its AI-powered language services. Jaide Health specializes in providing technology solutions that streamline communication in healthcare settings, aligning with AMN Healthcare's strategy to expand its digital offerings and improve efficiency for healthcare providers. This acquisition is …

Amneal gains FDA approval for four iohexol products

Amneal Pharmaceuticals received FDA approval for four new iohexol injection presentations, including three 350 mg iodine/mL vial sizes, expanding its generic contrast-agent portfolio. These products, targeting a $706 million U.S. market, are the first generic versions referencing OMNIPAQUE across these approved presentations. Amneal plans …

(AMN) Movement as an Input in Quant Signal Sets

This article provides an in-depth AI-driven analysis for Amn Healthcare Services Inc (AMN), indicating strong sentiment across all time horizons and compelling upside potential due to a lack of current resistance levels. It outlines specific institutional trading strategies, including long, breakout, and short positions, …

Is Amneal Pharmaceuticals (AMRX) Fairly Valued After Its Sharp Rerating?

Amneal Pharmaceuticals (AMRX) has experienced a significant rerating with strong short-term and long-term shareholder returns. While analysts consider it slightly undervalued at $18.25, a Discounted Cash Flow (DCF) model suggests a much higher fair value of $53.36, indicating potential undervaluation. The article highlights strategic …

AMN Healthcare Services (AMN) AGM 2026 Summary

The AMN Healthcare Services (AMN) 2026 Annual General Meeting (AGM) took place on May 1, 2026, where the Chair welcomed shareholders, established quorum, and introduced director nominees. Five items of business were presented, including the election of nine director nominees. A shareholder proposal by …

Amneal schedules July 30 call for second-quarter 2026 results

JAMNAAUTO Forecast — Price Target — Prediction for 2027

What's Driving Amneal's 2026 Growth Outlook?

Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?

Jamna Auto FY26 profit rises 28%, declares dividend

Jamna Auto Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026

Jamna Auto reports record revenue in FY26 led by volume surge

Do Jamna Auto Industries' (NSE:JAMNAAUTO) Earnings Warrant Your Attention?

Amneal Pharmaceuticals' (NASDAQ:AMRX) Solid Earnings Are Supported By Other Strong Factors

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Multi Year Returns And Recent Share Price Cooldown

MAP Holdings Limited Declares No Encumbrance of Shares in Jamna Auto Industries Limited for FY26

Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates

How The Amneal Pharmaceuticals (AMRX) Story Is Evolving Around 2026 Guidance And US$17 Targets

May 1 before the bell: Amneal to post quarterly results

Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy (AMRX)

Jamna Auto Industries - FIIs doubled their stake in 6 stocks; 3 surge over 15% just 2 months

Jamna Auto Industries Limited's (NSE:JAMNAAUTO) Share Price Not Quite Adding Up

Jamna Auto Industries Ltd. Share Price Live Today

Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Jamna Auto Industries Limited (NSE:JAMNAAUTO) Passed Our Checks, And It's About To Pay A ₹1.00 Dividend

JAMNAAUTO Share Price Today - Jamna Auto Industries Stock Analysis